People | Locations | Statistics |
---|---|---|
Naji, M. |
| |
Motta, Antonella |
| |
Aletan, Dirar |
| |
Mohamed, Tarek |
| |
Ertürk, Emre |
| |
Taccardi, Nicola |
| |
Kononenko, Denys |
| |
Petrov, R. H. | Madrid |
|
Alshaaer, Mazen | Brussels |
|
Bih, L. |
| |
Casati, R. |
| |
Muller, Hermance |
| |
Kočí, Jan | Prague |
|
Šuljagić, Marija |
| |
Kalteremidou, Kalliopi-Artemi | Brussels |
|
Azam, Siraj |
| |
Ospanova, Alyiya |
| |
Blanpain, Bart |
| |
Ali, M. A. |
| |
Popa, V. |
| |
Rančić, M. |
| |
Ollier, Nadège |
| |
Azevedo, Nuno Monteiro |
| |
Landes, Michael |
| |
Rignanese, Gian-Marco |
|
Brzózka, Zbigniew
in Cooperation with on an Cooperation-Score of 37%
Topics
Publications (10/10 displayed)
- 20192D Ti2C (MXene) as a novel highly efficient and selective agent for photothermal therapycitations
- 2017Microfluidic system for monitoring of cardiac (H9C2) cell proliferation
- 2016Evaluation of nanoencapsulated verteporfin's cytotoxicity using a microfluidic systemcitations
- 2012Effect of a high surface-to-volume ratio on fluorescence-based assayscitations
- 2007Further studies on the role of redox-active monolayer as intermediate phase of solid-state sensorscitations
- 2006Fabrication of ceramic-polymer microstructure for capillary electrophoresis with usage of photosensitive paste and thick film technology
- 2005Studies on ferrocene organothiol monolayer as an intermediate phase of potentiometric sensors with gold inner contactcitations
- 2004Design of ferrocene organothiol monolayer as intermediate phase for miniaturized electrochemical sensors with gold contact
- 2004Towards advanced chemical microsensors—an overviewcitations
- 2001Multi-ion analysis based on versatile sensor headcitations
Places of action
Organizations | Location | People |
---|
article
2D Ti2C (MXene) as a novel highly efficient and selective agent for photothermal therapy
Abstract
Photothermal therapy (PTT) has shown significant potential for anti-cancer modality. In this report, according to our best knowledge, we explore for the first time Ti2C-based MXene as a novel, highly efficient and selective agent for photothermal therapy (PTT). Ti2C superficially modified with PEG was obtained from the layered, commercially available Ti2AlC MAX phase in the process of etching aluminum layers using concentrated HF, and characterized by scanning electron microscopy (SEM), high-resolution transmission electron microscopy (HREM) as well as X-ray photoelectron spectroscopy for chemical analysis (ESCA-XPS). The PEG-coated Ti2C flakes showed a satisfactory photothermal conversion efficacy (PTCE) and good biocompatibility in wide range of the tested concentrations. Through in vitro studies, the PEG-modified Ti2C demonstrated notable NIR-induced ability to cancerous cells' ablation with minimal impact on non-malignant cells up to the concentration of 37.5 μg ml−1. The applied doses of Ti2C_PEG in our work were even 24 times lower comparing other MXene-based photothermal agents. This work is expected to expand the utility of 2D MXenes to biomedical applications through the development of entirely novel agents for photothermal therapy. This work is expected to expand the utility of 2D MXenes to biomedical applications through the development of entirely novel agents for photothermal therapy.